CMEA Ventures

Total investments

68

Average round size

23M

Portfolio companies

43

Rounds per year

2.62

Lead investments

5

Follow on index

0.37

Exits

31

Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareManufacturingMedical DeviceMedicalPharmaceuticalHardwareConsulting

Summary

CMEA Ventures is the famous VC, which was founded in 1997. The venture was found in North America in United States. The main office of represented VC is situated in the San Francisco.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the CMEA Ventures, startups are often financed by CMEA Capital, Trident Capital, Boston Millennia Partners. The meaningful sponsors for the fund in investment in the same round are Trident Capital, New Enterprise Associates, Boston Millennia Partners. In the next rounds fund is usually obtained by Trident Capital, Boston Millennia Partners, U.S. Venture Partners (USVP).

Among the most popular portfolio startups of the fund, we may highlight Myogen, Solyndra, Odyssey Logistics & Technology. The fund has exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Opposing the other organizations, this CMEA Ventures works on 16 percentage points more the average amount of lead investments. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2006. When the investment is from CMEA Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2003. Deals in the range of 10 - 50 millions dollars are the general things for fund.

We also calculated 1 valuable employee in our database.

Show more

Investments analytics

Analytics

Total investments
68
Lead investments
5
Exits
31
Rounds per year
2.62
Follow on index
0.37
Investments by industry
  • Biotechnology (25)
  • Health Care (21)
  • Software (16)
  • Pharmaceutical (11)
  • Information Technology (11)
  • Show 59 more
Investments by region
  • United States (60)
  • Singapore (3)
  • Canada (3)
Peak activity year
2005
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
68M
Group Appearance index
0.99
Avg. company exit year
11
Avg. multiplicator
1.53
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Caralyst Health 22 Sep 2022 Health Care, Hospital Seed United States, St Louis, Missouri
SurgiQuest 08 Jul 2011 Biotechnology, Health Care, Medical Device, Medical Late Stage Venture 19M United States, Connecticut
VeraLight 03 Jun 2008 Health Care, Medical, Diabetes Late Stage Venture 20M United States, New Mexico, Albuquerque
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.